{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:27:18Z","timestamp":1792211238082,"version":"4.4.0"},"reference-count":30,"publisher":"Korean Ophthalmological Society","issue":"6","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["ekjo.org"],"crossmark-restriction":true},"short-container-title":["Korean J Ophthalmol"],"published-print":{"date-parts":[[2025,12,5]]},"abstract":"<jats:p>Purpose: To evaluate current diagnostic and therapeutic practices among South Korean oculoplastic surgeons, with particular focus on adherence to guidelines and perspectives on emerging therapies such as teprotumumab.Methods: A nationwide, anonymized online survey was conducted in May 2025 among members of the Korean Society of Ophthalmic Plastic and Reconstructive Surgery (KSOPRS). The questionnaire collected data on physician demographics, diagnostic and monitoring approaches, therapeutic strategies for mild and moderate-to-severe thyroid eye disease (TED), management of dysthyroid optic neuropathy, and perspectives on teprotumumab treatment.Results: Thirty-two physicians participated in the study, most of whom practiced at tertiary centers. Most respondents (n = 28, 87.5%) utilized the Clinical Activity Score and the European Group on Graves\u2019 Orbitopathy severity classification. Intravenous (IV) glucocorticoid (GC) therapy was the predominant treatment for moderate-to-severe TED (n = 31, 96.9%), with adjunctive use of oral GCs, immunosuppressants (n = 13, 40.6%), and orbital radiotherapy (n = 29, 90.6%). In managing dysthyroid optic neuropathy, 19 respondents (59.4%) employed IV GC with radiotherapy, and 29 (90.6%) recommended decompression for refractory cases. Teprotumumab was considered primarily for GC-refractory cases, although its use was limited owing to cost and limited clinical experience. Functional assessments, including visual acuity and relative afferent pupillary defect, were prioritized over structural imaging in evaluating treatment response.Conclusions: South Korean oculoplastic surgeons generally follow international TED guidelines, favoring IV GC and conventional therapies over biologics due to access and cost barriers. As biologics like teprotumumab become more accessible, region-specific guidelines integrating global evidence and local healthcare constraints will be critical for optimized patient care.<\/jats:p>","DOI":"10.3341\/kjo.2025.0108","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:28:28Z","timestamp":1760070508000},"page":"532-541","update-policy":"https:\/\/doi.org\/10.3341\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Nationwide Survey by the Korean Society of Ophthalmic Plastic and Reconstructive Surgery (KSOPRS) on the Management of Thyroid Eye Disease in South Korea"],"prefix":"10.3341","volume":"39","author":[{"given":"Dongheon","family":"Surl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaesang","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewook","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Sook","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1893","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(25)00066-x"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/imj.15067"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000443828"},{"key":"ref4","first-page":"G43","volume-title":"The 2021 European Group on Graves\u2019 Orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy","author":"Bartalena","year":"2021"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2022.0251"},{"key":"ref6","first-page":"341","volume-title":"Teprotumumab for the treatment of active thyroid eye disease","author":"Douglas","year":"2020"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1997.2331047.x"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.82.7.773"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/iop.0000000000001150"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa646"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.177.3.2243967"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2011.12.005"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/opth.s476562"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(18)30020-2"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1140196"},{"key":"ref16","first-page":"1921","volume-title":"Real-world efficacy and safety of mycophenolate mofetil in active moderate-to-sight-threatening thyroid eye disease","author":"Quah Qin Xian","year":"2021"},{"key":"ref17","first-page":"181","volume-title":"Efficacy of tocilizumab in patients with moderate-to-severe corticosteroid-resistant Graves orbitopathy: a randomized clinical trial","author":"Perez-Moreiras","year":"2018"},{"key":"ref18","first-page":"422","volume-title":"Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves\u2019 orbitopathy: a randomized controlled study","author":"Salvi","year":"2015"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/iop.0000000000001003"},{"key":"ref20","first-page":"273","volume-title":"Consensus statement of the European Group on Graves\u2019 Orbitopathy (EUGOGO) on management of GO","author":"Bartalena","year":"2008"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-023-02036-0"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae222"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(21)00056-5"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad637"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.04.024"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad213"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/iop.0000000000002563"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2024.06.003"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2022.0172"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1530\/etj-23-0269"}],"container-title":["Korean Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ekjo.org\/upload\/pdf\/kjo-2025-0108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/ekjo.org\/journal\/view.php?doi=10.3341\/kjo.2025.0108","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/ekjo.org\/upload\/pdf\/kjo-2025-0108.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T08:50:53Z","timestamp":1765875053000},"score":1,"resource":{"primary":{"URL":"http:\/\/ekjo.org\/journal\/view.php?doi=10.3341\/kjo.2025.0108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"URL":"https:\/\/doi.org\/10.3341\/kjo.2025.0108","relation":{},"ISSN":["1011-8942","2092-9382"],"issn-type":[{"value":"1011-8942","type":"print"},{"value":"2092-9382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"2025-07-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-10","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-05","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}